Nonconventional Therapeutics against .

Grunenwald CM, Bennett MR, Skaar EP
Microbiol Spectr. 2018 6 (6)

PMID: 30547858 · PMCID: PMC6296826 · DOI:10.1128/microbiolspec.GPP3-0047-2018

is one of the most important human pathogens that is responsible for a variety of diseases ranging from skin and soft tissue infections to endocarditis and sepsis. In recent decades, the treatment of staphylococcal infections has become increasingly difficult as the prevalence of multi-drug resistant strains continues to rise. With increasing mortality rates and medical costs associated with drug resistant strains, there is an urgent need for alternative therapeutic options. Many innovative strategies for alternative drug development are being pursued, including disruption of biofilms, inhibition of virulence factor production, bacteriophage-derived antimicrobials, anti-staphylococcal vaccines, and light-based therapies. While many compounds and methods still need further study to determine their feasibility, some are quickly approaching clinical application and may be available in the near future.

MeSH Terms (14)

Anti-Bacterial Agents Antibodies, Bacterial Bacteriophages Biofilms Drug Discovery Drug Resistance, Multiple, Bacterial Humans Phage Therapy Photochemotherapy Quorum Sensing Staphylococcal Infections Staphylococcus aureus Virulence Virulence Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links